Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 16, 2005. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 12,300 Ordinary Shares from the GlaxoSmithKline Employee Trust ("the GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on December 14, 2005, and was advised to the company on December 15, 2005.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on business strategy, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the shares held by the trust in the same capacity as other employees.
Key Facts for Investor Verification
- Transaction Type: Transfer of 12,300 Ordinary Shares from the GSK Trust to employee plan participants.
- Transaction Date: December 14, 2005.
- Directors Involved: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop have interests in the trust shares.
- Regulatory Basis: Notification made in accordance with Disclosure Rule 3.1.4R(1)(b).
- Financial Data: No financial metrics are included in this specific filing.